David Colleran
2021
In 2021, David Colleran earned a total compensation of $1.4M as EVP, General Counsel and Secretary at Anika Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $194,597 |
|---|---|
| Option Awards | $375,853 |
| Salary | $432,400 |
| Stock Awards | $375,598 |
| Other | $22,064 |
| Total | $1,400,513 |
Colleran received $432.4K in salary, accounting for 31% of the total pay in 2021.
Colleran also received $194.6K in bonus, $375.9K in option awards, $375.6K in stock awards and $22.1K in other compensation.
Rankings
In 2021, David Colleran's compensation ranked 7,545th out of 12,404 executives tracked by ExecPay. In other words, Colleran earned more than 39.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,545 out of 12,404 | 39th |
Division Manufacturing | 3,321 out of 5,494 | 40th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 435 out of 798 | 46th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 273 out of 519 | 47th |
Industry Surgical and Medical Instruments and Apparatus | 173 out of 324 | 47th |
Source: SEC filing on April 27, 2022.
Colleran's colleagues
We found four more compensation records of executives who worked with David Colleran at Anika Therapeutics in 2021.